Core Viewpoint - Tianan Health (00383) reported a decline in revenue and profit for the six months ending June 30, 2025, primarily due to decreased operational income in the medical segment and increased non-cash fair value losses on investment properties [1] Financial Performance - The company achieved revenue of HKD 783 million, a year-on-year decrease of 4.67% [1] - Profit attributable to shareholders was HKD 11.979 million, down 44.69% year-on-year [1] - Basic earnings per share were HKD 0.0111 [1] Contributing Factors - The decline in revenue and profit was mainly attributed to reduced operational income in the medical segment [1] - There was an increase in non-cash fair value losses on investment properties [1] - However, this decline was partially offset by a reduction in employee benefit expenses, net unrealized exchange gains, and decreased income tax expenses [1]